These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1899408)

  • 1. Do non-steroidal anti-inflammatory drugs increase colonic permeability?
    Jenkins AP; Trew DR; Crump BJ; Nukajam WS; Foley JA; Menzies IS; Creamer B
    Gut; 1991 Jan; 32(1):66-9. PubMed ID: 1899408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous administration of lactulose and 51Cr-ethylenediaminetetraacetic acid. A test to distinguish colonic from small-intestinal permeability change.
    Jenkins AP; Nukajam WS; Menzies IS; Creamer B
    Scand J Gastroenterol; 1992 Sep; 27(9):769-73. PubMed ID: 1411284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of mannitol, lactulose and 51Cr-labelled ethylenediaminetetra-acetate as markers of intestinal permeability in man.
    Elia M; Behrens R; Northrop C; Wraight P; Neale G
    Clin Sci (Lond); 1987 Aug; 73(2):197-204. PubMed ID: 3115663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the lactulose/mannitol and 51Cr-ethylenediaminetetraacetic acid/14C-mannitol methods for intestinal permeability.
    Blomquist L; Bark T; Hedenborg G; Norman A
    Scand J Gastroenterol; 1997 Aug; 32(8):805-12. PubMed ID: 9282973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between the lactulose/mannitol and 51Cr-ethylenediaminetetraacetic acid/14C-mannitol methods for intestinal permeability. Frequency distribution pattern and variability of markers and marker ratios in healthy subjects.
    Blomquist L; Bark T; Hedenborg G; Svenberg T; Norman A
    Scand J Gastroenterol; 1993 Mar; 28(3):274-80. PubMed ID: 8446853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactulose, 51Cr-labelled ethylenediaminetetra-acetate, L-rhamnose and polyethyleneglycol 400 [corrected] as probe markers for assessment in vivo of human intestinal permeability.
    Maxton DG; Bjarnason I; Reynolds AP; Catt SD; Peters TJ; Menzies IS
    Clin Sci (Lond); 1986 Jul; 71(1):71-80. PubMed ID: 3086024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs.
    Bjarnason I; Williams P; So A; Zanelli GD; Levi AJ; Gumpel JM; Peters TJ; Ansell B
    Lancet; 1984 Nov; 2(8413):1171-4. PubMed ID: 6150232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non-steroidal anti-inflammatory agents increase intestinal permeability].
    Auer IO; Habscheid W; Hiller S; Gerhards W; Eilles C
    Dtsch Med Wochenschr; 1987 Jun; 112(26):1032-7. PubMed ID: 3109868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo influence of nicotine on human basal and NSAID-induced gut barrier function.
    Suenaert P; Bulteel V; Den Hond E; Geypens B; Monsuur F; Luypaerts A; Ghoos Y; Rutgeerts P
    Scand J Gastroenterol; 2003 Apr; 38(4):399-408. PubMed ID: 12739712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of four markers of intestinal permeability in control subjects and patients with coeliac disease.
    Bjarnason I; Maxton D; Reynolds AP; Catt S; Peters TJ; Menzies IS
    Scand J Gastroenterol; 1994 Jul; 29(7):630-9. PubMed ID: 7939400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oral adenosine 5'-triphosphate and adenosine in enteric-coated capsules on indomethacin-induced permeability changes in the human small intestine: a randomized cross-over study.
    Bours MJ; Bos HJ; Meddings JB; Brummer RJ; van den Brandt PA; Dagnelie PC
    BMC Gastroenterol; 2007 Jun; 7():23. PubMed ID: 17578566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of polysucrose 15000, 51Cr-labelled ethylenediaminetetraacetic acid, and 14C-mannitol as markers of intestinal permeability in man.
    Oman H; Blomquist L; Henriksson AE; Johansson SG
    Scand J Gastroenterol; 1995 Dec; 30(12):1172-7. PubMed ID: 9053970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a triple sugar test of colonic permeability in humans.
    Anderson AD; Jain PK; Fleming S; Poon P; Mitchell CJ; MacFie J
    Acta Physiol Scand; 2004 Oct; 182(2):171-7. PubMed ID: 15450113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiinflammatory drug-induced small intestinal permeability: the rat is a suitable model.
    Davies NM; Wright MR; Jamali F
    Pharm Res; 1994 Nov; 11(11):1652-6. PubMed ID: 7870685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of local versus systemic effects of non-steroidal anti-inflammatory drugs in increasing small intestinal permeability in man.
    Bjarnason I; Fehilly B; Smethurst P; Menzies IS; Levi AJ
    Gut; 1991 Mar; 32(3):275-7. PubMed ID: 1901563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal permeability to [51Cr]EDTA in infectious diarrhea.
    Zuckerman MJ; Watts MT; Bhatt BD; Ho H
    Dig Dis Sci; 1993 Sep; 38(9):1651-7. PubMed ID: 8359077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small bowel and colonic permeability to 51Cr-EDTA in patients with active inflammatory bowel disease.
    Jenkins RT; Ramage JK; Jones DB; Collins SM; Goodacre RL; Hunt RH
    Clin Invest Med; 1988 Apr; 11(2):151-5. PubMed ID: 3135136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of intestinal permeability changes induced by nonsteroidal anti-inflammatory drugs in the rat.
    Ford J; Martin SW; Houston JB
    J Pharmacol Toxicol Methods; 1995 Sep; 34(1):9-16. PubMed ID: 7496048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal mucosal permeability in inflammatory rheumatic diseases. I. Role of antiinflammatory drugs.
    Mielants H; Goemaere S; De Vos M; Schelstraete K; Goethals K; Maertens M; Ackerman C; Veys EM
    J Rheumatol; 1991 Mar; 18(3):389-93. PubMed ID: 1906938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental non-steroidal anti-inflammatory drug-induced enteropathy in the rat: similarities to inflammatory bowel disease and effect of thromboxane synthetase inhibitors.
    Banerjee AK; Peters TJ
    Gut; 1990 Dec; 31(12):1358-64. PubMed ID: 1979954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.